NUZ neurizon therapeutics limited

Ann: Positive 8-month Interim Data from OLE Study, page-49

  1. 3,280 Posts.
    lightbulb Created with Sketch. 1897
    I'm guessing the market didn't like the fact that at the very bottom of the release it states another patient sadly passed away due to respiratory failure. Terrible.

    Must admit I missed that on the first read. From an objective perspective I wonder where that patient sat on the last round of ALSFRS scoring. Remember some where 'stable' while others were still declining. May provide some insight into how reliable the ALSFRS readouts actually are.

    MT maybe one to cover off on. Was this patient 'stable' or one still declining?

    Didn't MT also say in the briefing they needed one more patient to pass before they could determine the survival rate?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $81.23M
Open High Low Value Volume
17.0¢ 17.0¢ 17.0¢ $1.988K 11.69K

Buyers (Bids)

No. Vol. Price($)
3 79364 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 57398 4
View Market Depth
Last trade - 10.09am 17/06/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.